R-Tech Ueno Initiates a Phase I Clinical Study of RK-023 for the Treatment of Hypotrichosis of the Eyelashes

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573) is pleased to announce the initiation of a Phase I clinical study of RK-023, a new compound that is being developed for the treatment of hypotrichosis of the eyelashes(1). The details of the trial are summarized below.

Back to news